SafeHeal Closes €40 Million Financing Co-Led by Sofinnova Partners and Genesis MedTech To Finance Its Colovac Device Through a Pivotal Clinical Trial in the United States
Summary
PARIS, FRANCE / ACCESSWIRE / January 31, 2022 / SafeHeal, a leading innovator in the field of digestive surgery and developer of the Colovac device, announced today a successful 40M€ financing, co-led by Sofinnova Partners and Genesis MedTech Group. The Colovac solution addresses the most serious complication of colorectal surgery - anastomotic leakage, the leaking of fecal content in the abdominal cavity, which can lead to sepsis or even death. "This collaboration will accelerate the development of this world-class endoluminal bypass sheath, benefiting both patients and practitioners," said Warren Wang, Chairman and Chief Executive Officer of Genesis MedTech Group. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future. Founded in 1972, Sofinnova Partners is a deeply-established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe.